Publicacions recents

Llista de publicacions més recents liderades per la Unitat de Memòria de l’Hospital de Sant Pau:

  1. Dissociating language switching from executive control in bilinguals with MCI. Calabria, M, Suades, A, Juncadella, M et al. Cortex 2024
    PMID:39765077

  2. Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report. Rodríguez-Baz, Í, Benejam, B, Morcillo-Nieto, AO et al. Neurology 2025
    PMID:39689339

  3. New treatments in Alzheimer's disease. Lleó, A Med Clin (Barc) 2024
    PMID:39616028

  4. Amyloid-lowering treatment in Alzheimer's disease. Jessen, F, Frölich, L, Hort, J et al. Lancet 2024
    PMID:39551061

  5. What Can We Learn About Alzheimer's Disease from People with Down Syndrome?. Maure-Blesa, L, Rodríguez-Baz, I, Carmona-Iragui, M et al. Curr Top Behav Neurosci 2024
    PMID:39509049

  6. Challenges in the practical implementation of blood biomarkers for Alzheimer's disease. Schöll, M, Verberk, IMW, Del Campo, M et al. Lancet Healthy Longev 2024
    PMID:39369727

  7. Context matters: the evolving use of biomarkers in Alzheimer's disease care. Fortea, J EBioMedicine 2024
    PMID:39366842

  8. Characterization of white matter hyperintensities in Down syndrome. Morcillo-Nieto, AO, Zsadanyi, SE, Arriola-Infante, JE et al. Alzheimers Dement 2024
    PMID:39087352

  9. Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome. Zsadanyi, SE, Morcillo-Nieto, AO, Aranha, MR et al. Neurology 2024
    PMID:39074338

  10. Correction: Diagnostic performance of plasma pTau217, pTau181, Aβ1‑42 and Aβ1‑40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Arranz, J, Zhu, N, Rubio-Guerra, S et al. Alzheimers Res Ther 2024
    PMID:39068457

  11. APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets. Sirisi, S, Sánchez-Aced, É, Belbin, O et al. Alzheimers Res Ther 2024
    PMID:38951839

  12. Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Arranz, J, Zhu, N, Rubio-Guerra, S et al. Alzheimers Res Ther 2024
    PMID:38926773

  13. Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019. Rubenstein, E, Tewolde, S, Skotko, BG et al. Am J Med Genet C Semin Med Genet 2024
    PMID:38925597

  14. What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?. Lleó, A, Alcolea, D Neurology 2024
    PMID:38830183

  15. Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI. Aranha, MR, Montal, V, van den Brink, H et al. Alzheimers Dement 2024
    PMID:38644660

  16. Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Arranz, J, Zhu, N, Rubio-Guerra, S et al. Res Sq 2023
    PMID:38168408

  17. Down Syndrome in a New Era for Alzheimer Disease. Rafii, MS, Fortea, J JAMA 2023
    PMID:37991807

  18. Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum. Illán-Gala, I, Lorca-Puls, DL, Tee, BL et al. Brain 2024
    PMID:37988272

  19. Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices. Grasso, SM, Wagner Rodríguez, CA, Montagut Colomer, N et al. J Alzheimers Dis 2023
    PMID:37980666

  20. Compounded inequality: racial disparity and Down syndrome. McGlinchey, E, Iulita, MF, Fortea, J et al. Lancet Public Health 2023
    PMID:37898515

  21. Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Zhu, N, Santos-Santos, M, Illán-Gala, I et al. Transl Neurodegener 2023
    PMID:37158972

  22. Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome. Iulita, MF, Bejanin, A, Vilaplana, E et al. Brain Commun 2023
    PMID:37056479

  23. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome. Videla, L, Benejam, B, Carmona-Iragui, M et al. Alzheimers Dement 2023
    PMID:37038748

  24. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome. Rozalem Aranha, M, Iulita, MF, Montal, V et al. Alzheimers Dement 2023
    PMID:37021589

  25. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. Montoliu-Gaya, L, Alcolea, D, Ashton, NJ et al. EBioMedicine 2023
    PMID:37002988

  26. Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist. Alcolea, D, Beeri, MS, Rojas, JC et al. Neurology 2023
    PMID:36878698

  27. Correction: Cortical microstructure in primary progressive aphasia: a multicenter study. Illán-Gala, I, Montal, V, Borrego-Écija, S et al. Alzheimers Res Ther 2023
    PMID:36739431

  28. Amyloid precursor protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's disease. Ferrer-Raventós, P, Puertollano-Martín, D, Querol-Vilaseca, M et al. Neuropathol Appl Neurobiol 2023
    PMID:36702749

  29. Early Motor Changes in Genetic Frontotemporal Dementia. Lleó, A, Illán-Gala, I Neurology 2022
    PMID:36219793

  30. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease. Benejam, B, Aranha, MR, Videla, L et al. Alzheimers Res Ther 2022
    PMID:36057615

Search PubMed